CompletedNot Applicable

Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

United States600 participantsStarted 2006-08

Plain-language summary

The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also determine the correlation of C. pneumoniae infection with the development of obliterans in lung transplant recipients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who have undergone lung transplantation or will undergo a lung transplant at the University of Pittsburgh Medical Center and are alive following transplant period will be eligible for the study. Exclusion Criteria: * Subjects not willing to participate in the research study.

What they're measuring

long term outcome after lung transplantation

Timeframe: five year follow up

Trial details

NCT IDNCT00177918

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-01

View on ClinicalTrials.gov More Disorder Related to Lung Transplantation trials